Trump claims he’s lowering drug prices. Pharma execs say it’s a “convenient subject matter” ahead of the election.


“The drug company CEOs made the mistake of saying the quiet part out loud: Trump has no intention of actually implementing policies that would meaningfully help patients or risk hurting the pharmaceutical industry’s bottom lines,” Eli Zupnick, a spokesman for the progressive government watchdog group Accountable.US, told Salon.

“His executive orders, which are unlikely to be implemented this year and wouldn’t have meaningful impacts on drug prices even if they were, are nothing more than last-ditch publicity stunts to distract people from the fact that he hasn’t come close to delivering on his promises to reduce the prices of prescription drugs.”